SEBI orders winding-up of Growpital farmland investment scheme

The Securities and Exchange Board of India (SEBI) has ordered the winding-up of the Growpital farmland investment scheme. The regulator found that the company raised ₹192.88 crore from 5,208 investors through an unauthorised Collective Investment Scheme (CIS). As a result, the scheme is being wound up to ensure that the invested capital is returned to the investors.
This action highlights the risks associated with unregulated investment products. Investors should be cautious of schemes that promise high returns without proper regulatory approval. SEBI's directive ensures that the principal amount is refunded, along with 12 per cent interest, to compensate investors for the delay.
Going forward, investors should verify the regulatory status of any investment platform before committing funds. Monitoring SEBI's actions can help in identifying potential risks. It is crucial to rely on registered entities to safeguard your investments.
Excerpt from BusinessLine
The Securities and Exchange Board of India (SEBI) has ordered the winding-up of Growpital’s farmland investment scheme, holding that the platform operated an unauthorised collective investment scheme (CIS) and raised ₹192.88 crore from 5,208 investors. In its final order passed on Monday, SEBI held all 28 noticees…Read the original at BusinessLine
Key takeaways
- Category: Economy.
- AI reads the tone as negative (potentially bearish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.















